8-K
Current Report
SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-014627
Material agreement · Acquisition or sale completed
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading sabs-20250130.htm…